What does VYNE Therapeutics, Inc. do?

Jun 22 2025 07:06 PM IST
share
Share Via
VYNE Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for pruritus related to dermatologic conditions, with a market cap of $15.31 million and recent net sales of $0 million. The company is currently operating at a loss, with a net profit of -$9 million as of March 2025.
Overview:
VYNE Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for pruritus associated with dermatologic conditions, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company. Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -9 Million (Quarterly Results - Mar 2025) Market cap: USD 15.31 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.14 Return on Equity: -95.55% Price to Book: 0.35 Contact Details: Address: 520 U.S. Highway 22, Suite 204, BRIDGEWATER NJ: 08807 Tel: 1 650 4861416 Fax: 1 302 6555049 Website: http://www.menlotherapeutics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is VYNE Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 08:10 PM IST
share
Share Via
Is VYNE Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:23 AM IST
share
Share Via
Is VYNE Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 09:07 AM IST
share
Share Via
Who are in the management team of VYNE Therapeutics, Inc.?
Jun 22 2025 10:45 PM IST
share
Share Via
How big is VYNE Therapeutics, Inc.?
Jun 22 2025 06:17 PM IST
share
Share Via